Intravenous Solutions Market To Reach $28.7 Billion By 2033

August 2026 | Report Format: Electronic (PDF)

Intravenous Solutions Market Growth & Trends

The global intravenous solutions market size is anticipated to reach USD 28.7 billion by 2033, registering a CAGR of 5.8% from 2026 to 2033, according to a new report by Grand View Research, Inc. The high prevalence of preterm births, especially in emerging economies such as India and China, is expected to drive market growth during the forecast period. According to WHO, 1 in 10 babies are born preterm, and this is a global concern. Thus, the high incidence of preterm births in emerging economies, improved healthcare infrastructure, and growing healthcare expenditure & patient awareness are expected to be high impact rendering drivers of the market during the forecast period.

The use of parenteral lipid emulsions is driven by the extensive focus of various authorities to limit preterm birth mortality. As of 2021, the preterm birth rate in the U.S. was about 10.5%. Moreover, the annual societal, and economic cost was estimated at USD 25.2 billion for preterm births. Hence, the presence of many neonates requiring supplementary postbirth nutrition is expected to boost the market demand over the forecast period.

In addition, several studies justify the use of parenteral nutrition for patients suffering from malnutrition problems, which increased during the pandemic, leading to market growth. For instance, according to an article published in the Journal of the Academy of Nutrition and Dietetics, many patients admitted to the ICU for COVID-19 treatment suffer from acute malnourishment. Hence, the usage of parenteral nutrition products is expected to increase in the market during the pandemic.

In COVID-19-positive patients, high deficiency of specific micronutrients and vitamins has been reported to be detrimental. Thus, intravenous administration is recommended in such patients to meet the recommended dietary intake. Physicians and nutrition specialists preferred parenteral nutrition over enteral nutrition in COVID-19 patients since enteral nutrition specifically requires the setup of nasogastric tubes, which hampers the noninvasive ventilation provided to COVID-19 patients. The increased risk of nutritional solution aspiration and underfeeding in hospitalized patients for COVID-19 has led to increased adoption of parenteral nutrition.

key Request a free sample copy or view report summary: Intravenous Solutions Market Report

Intravenous Solutions Market Report Highlights

The crystalloid solutions segment held the largest revenue share of 58.0% in the intravenous solutions market in 2025. This dominance is attributed to the widespread use of normal saline, Lactated Ringer's, dextrose solutions, and balanced crystalloids for fluid resuscitation, electrolyte replacement, and management of dehydration.
The institutional segment accounted for the largest revenue share of 75.0% in 2025. The dominance of this segment is attributed to the high consumption of IV solutions across hospitals, clinics, ambulatory surgical centers, and long-term care facilities.
The hospitals segment held a significant share in the market, due to the increasing demand for IV therapy in critical care and inpatient settings. Hospitals handle a large volume of patients requiring fluid replacement, electrolyte balancing, and parenteral nutrition, making IV solutions an important component of patient management.

Intravenous Solutions Market Segmentation

Grand View Research has segmented the global intravenous solutions market report based on product type, sales channel, end use, and region:

Intravenous Solutions Product Type Outlook Revenue, USD Million, 2021 - 2033)

Crystalloid Solutions
- Normal Saline (0.9% Sodium Chloride)
- Half Normal Saline (0.45% Sodium Chloride)
- Dextrose Solutions
  - Dextrose 5% Injection
  - Dextrose 10% Injection
  - Dextrose 50% Injection
- Dextrose-Saline Solutions
  - Dextrose 5% and Sodium Chloride 0.9% Infusion
  - Dextrose 4.3% and Sodium Chloride 0.18% Infusion
- Ringer's Solution
- Lactated Ringer's Solution
- Balanced Crystalloid Solutions
  - Plasma-Lyte
  - Normosol
- Hypertonic Saline (3%, 5%, etc.)
- Other Crystalloid Solutions
Colloid Solutions
Parenteral Nutrition (PN) Solutions
- Total Parenteral Nutrition (TPN)
  - Standard TPN
  - Customized TPN
  - Ready-to-use Multi-Chamber Bags
- Peripheral Parenteral Nutrition (PPN)
  - Ready-to-use PPN
  - Customized PPN